DISEASE-MODIFYING ANTIRHEUMATIC DRUG (DMARD)
Myfortic is a prescription drug approved by the Food and Drug Administration (FDA) to prevent organ rejection in people with kidney transplants in conjunction with Cyclosporine and corticosteroids. Myfortic is sometimes prescribed to treat lupus, particularly in cases involving kidney disease. Myfortic is also known by its drug name, Mycophenolic acid.
Myfortic is a disease-modifying antirheumatic drug (DMARD), a type of medication that suppresses the immune system and fights inflammation. Myfortic is believed to work by preventing the production of DNA and impairing function in cells, including immune cells that contribute to inflammation.
How do I take it?
Myfortic is generally taken orally twice daily.
Myfortic comes in delayed-release tablet form.
The FDA-approved label for Myfortic lists common side effects including insomnia, nausea, diarrhea, vomiting, constipation, upset stomach, urinary tract infections, other infections, and blood cell disorders.
Rare but serious side effects listed for Myfortic include severe infections and blood cell disorders.
For more details about this treatment, visit:
Myfortic – Novartis
Mycophenolate Mofetil (CellCept) and Mycophenolate Sodium (Myfortic) – American College of Rheumatology